Skip to content

King Pharmaceuticals KG Increase in unearned premiums

Increase in unearned premiums at other companies

W.R. Berkley logo
W.R. BerkleyWRB
-$59.17M+51.1%
Universal Insurance Holdings logo
Universal Insurance HoldingsUVE
$24.87M-46.1%
Greenlight Capital RE, Ltd. logo
Greenlight Capital RE, Ltd.GLRE
-$29.33M+42.4%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInUnearnedPremiumsNet.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's increase in unearned premiums.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's increase in unearned premiums?
King Pharmaceuticals (KG) reported increase in unearned premiums of $503K in Q1 2026.
What does increase in unearned premiums mean?
The net change in the portion of premiums written that has not yet been earned by the insurer because the policy period remains active. An increase in this balance indicates growth in future revenue recognition, while a decrease suggests the realization of previously deferred premiums. It serves as a bridge between cash-based premiums written and accrual-based premiums earned.